Steven Cobourn
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Steven P.
Cobourn is Chief Financial Officer at NextCure, Inc. since 2018.
Formerly, Chief Financial Officer at Vaccinex, Inc. from 2014 to 2018.
Treasurer & Vice President-Finance at Otsuka America Pharmaceutical, Inc. from 2003 to 2014.
Completed undergraduate education at Drexel University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NEXTCURE, INC. -.--% | 30-01-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NEXTCURE, INC. | Financieel Directeur/CFO | 01-01-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
| VACCINEX, INC. | Financieel Directeur/CFO | 01-01-2018 |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Financieel Directeur/CFO | 01-04-2014 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Vaccinex, Inc.
Vaccinex, Inc. BiotechnologyHealth Technology Discovers and develops targeted biotherapeutics | Health Technology |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
NextCure, Inc.
NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau